Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access,

Clinical trials of the COVID-19 vaccine candidate NDV-HXP-S, which includes a key protein developed at the University of Texas at Austin, began in …, Clinical trials of the COVID-19 vaccine candidate NDV-HXP-S, which includes a key protein developed at the University of Texas at Austin, began in …, Read More

Scroll to Top